[Pharmaceutical Products and Medical Devices: Authorization and Conformity Assessment Procedures, Regulatory Data Protection, Patent Protection and Supplementary Protection Certificate].

IF 0.2 Q4 MEDICINE, GENERAL & INTERNAL
Claudia Seitz
{"title":"[Pharmaceutical Products and Medical Devices: Authorization and Conformity Assessment Procedures, Regulatory Data Protection, Patent Protection and Supplementary Protection Certificate].","authors":"Claudia Seitz","doi":"10.23785/TU.2024.06.006","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Pharmaceutical products and medical devices can pose a potenzial risk to health. They may therefore only be placed on the market if their safety, efficacy and quality have been proven. The safety requirements are not to be understood as absolute. Rather, the safety assessment is based on a risk-benefit assessment. Pharmaceutical products and medical devices are subject to different requirements, whereby pharmaceutical products are subject to an authorization procedure, while medical devices have to undergo a conformity assessment procedure. This article first sets out the basic principles and the system of therapeutic products law and discusses the categorization of pharmaceutical products and medical devices as well as their differentiation from other products, in particular foodstuffs and cosmetics. The main features of placing pharmaceutical products on the market are then presented, with a focus on the authorization procedures for pharmaceutical products. This article also provides a brief overview of the protection rights for pharmaceutical products. In addition to the protection rights under the Therapeutic Products Act, the regulatory data protection, there are also protection rights under intellectual property law. In addition to the patent, intellectual property law grants another protection right for products that require an authorization in order to be placed on the market. The supplementary protection certificate, which is only granted to medicinal products and plant protection products as products that require an authorization, is intended to partially compensate for the lack of possibility of using the patented invention during the approval process. Due to the scope of the medicinal products and intellectual property law regulations mentioned, this article must limit itself to selected areas in an overview.</p>","PeriodicalId":44874,"journal":{"name":"THERAPEUTISCHE UMSCHAU","volume":"81 6","pages":"214-222"},"PeriodicalIF":0.2000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"THERAPEUTISCHE UMSCHAU","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23785/TU.2024.06.006","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Pharmaceutical products and medical devices can pose a potenzial risk to health. They may therefore only be placed on the market if their safety, efficacy and quality have been proven. The safety requirements are not to be understood as absolute. Rather, the safety assessment is based on a risk-benefit assessment. Pharmaceutical products and medical devices are subject to different requirements, whereby pharmaceutical products are subject to an authorization procedure, while medical devices have to undergo a conformity assessment procedure. This article first sets out the basic principles and the system of therapeutic products law and discusses the categorization of pharmaceutical products and medical devices as well as their differentiation from other products, in particular foodstuffs and cosmetics. The main features of placing pharmaceutical products on the market are then presented, with a focus on the authorization procedures for pharmaceutical products. This article also provides a brief overview of the protection rights for pharmaceutical products. In addition to the protection rights under the Therapeutic Products Act, the regulatory data protection, there are also protection rights under intellectual property law. In addition to the patent, intellectual property law grants another protection right for products that require an authorization in order to be placed on the market. The supplementary protection certificate, which is only granted to medicinal products and plant protection products as products that require an authorization, is intended to partially compensate for the lack of possibility of using the patented invention during the approval process. Due to the scope of the medicinal products and intellectual property law regulations mentioned, this article must limit itself to selected areas in an overview.

【药品和医疗器械:授权和合格评定程序、监管数据保护、专利保护和补充保护证书】。
药品和医疗器械可能对健康构成潜在风险。因此,只有在其安全性、有效性和质量得到证实的情况下,它们才能投放市场。安全要求不应被理解为绝对的。相反,安全性评估是基于风险-收益评估。医药产品和医疗器械有不同的要求,其中医药产品要经过授权程序,医疗器械要经过合格评定程序。本文首先阐述了治疗产品法的基本原则和体系,讨论了药品和医疗器械的分类及其与其他产品,特别是食品和化妆品的区别。然后介绍了将药品投放市场的主要特点,重点是药品的授权程序。本文还简要介绍了医药产品的保护权。除了《治疗产品法》(Therapeutic Products Act)下的保护权利、监管数据保护之外,还有知识产权法下的保护权利。除了专利之外,知识产权法还为需要授权才能投放市场的产品授予另一种保护权利。补充保护证书,仅对医药产品和植物保护产品作为需要授权的产品授予,旨在部分补偿专利发明在批准过程中缺乏使用可能性。由于提及的医药产品和知识产权法律法规的范围,本文必须将自己限制在概述中选定的领域。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
THERAPEUTISCHE UMSCHAU
THERAPEUTISCHE UMSCHAU MEDICINE, GENERAL & INTERNAL-
CiteScore
0.50
自引率
0.00%
发文量
75
期刊介绍: Monat für Monat ein aktuelles Thema der praktischen Medizin - als Sammlung ein hochaktuelles Nachschlagewerk.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信